Eli Lilly and Company LLY Announces 23B Planned Acquisition of Ajax Therapeutics to Bolster Hematological Oncology Pipeline US Residential Construction Sourcing Shift Rising Direct Imports of Chinese Building Materials STOK Stoke Therapeutics Q4 2025 EPS misses estimates by 333 pushing shares 258 lower in todays session